EichorEICHOR
Study identifier: NCT05722340 Synced from ClinicalTrials.gov · August 08, 2026
● Study status: CompletedNIVATS-2

NIVATS Versus IGAVATS: a Pilot Trial Addressing Biopsy Quality in Undetermined Interstitial Lung Diseases

Condition: Lung Diseases, Interstitial  ·  Sponsor: University Hospital, Montpellier

PhaseNA
Planned participants24
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNoCheck eligibility criteria ↓
WhereMontpellier, France

Sponsor, CRO or site team? See where this study is running → — listed sites, countries and recruiting context. Everything below is written for patients and caregivers.

About this study

The main objective of this study is to compare two independent groups of patients requiring lung biopsy for undetermined interstitial lung disease (ILD) in terms of diagnostic confidence as determined by histologists.

This description comes directly from the study's public registry record.

Talk to the study team

No contact information is available for this study as per the public registry record.

Always discuss trial participation with your own doctor first.

Full eligibility criteria (exactly as the study team wrote them)

Inclusion Criteria: * Patient with purported interstitial lung disease * Patient requiring a surgical lung biopsy to reinforce diagnosis according to current recommendations and validated by a multidisciplinary assessment * Minimum age: 18 years Exclusion Criteria: * Contra-indication for surgery * Uncontrolled oesophageal gastric reflux despite optimal treatment * Thoracic deformation (For example, pectus excavatum/carinatum or major scoliosis) * Risk of pleural adhesion (For example, patient who has already undergone thoracic surgery) * History of abnormal bleeding * Predictable risk of difficult intubation * Body mass index (BMI) \> 30 * Severe cardiovascular comorbidity (For example, instable ischemic cardiomyopathy) * Unable to comply with all trial procedures/visits (For example, language barriers, upcoming move of household to another region, unwillingness to schedule the required followup visits.) * Protected populations according to the French Public Health Code Articles L1121-5,6,8 (For example, pregnant, parturient or lactating women, prisoners, adults under guardianship or otherwise unable to consent.) * Potential interference from another study (The patient is participating in another interventional study, or has done so in the past month, or is affected by an exclusion period stipulated by a previous study.) * Non-beneficiary of the French single-payer national medical insurance system * Lack of signed informed consent

Reproduced word-for-word from the public registry record — the study team can answer questions about it.

Locations (1)

Département d'Anesthésie et Réanimation Cardiothoracique - CHU Arnaud de VilleneuveMontpellier, France

More studies in these areas

This study lists sites in the areas below. Each link shows other recruiting studies near that city, from the public registry record.

Montpellier

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.

Look up another condition
Look up another city
Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →